medigraphic.com
Revista Médica Sinergia

2022, Number 03

Next >>

Revista Médica Sinergia 2022; 7 (03)

Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis

Angulo MLC, Garita ME, Salas MJP

Language: Spanish
References: 18
Page:
PDF size: 205.23 Kb.


ABSTRACT

Anti-N-methyl-D-aspartate receptor encephalitis is a neurological entity that occurs mainly with psychiatric manifestations. In most cases it is a para-neoplastic presentation of an ovarian teratoma in young women, so the presence of this entity should always be considered in this ethereal group, when suspecting any psychiatric pathology of a psychotic nature. The diagnosis of this pathology is made by finding the antibodies in the lumbar puncture. Usually, the pathology remits when the underlying tumor is removed, in addition the usage of steroids and immunoglobulins to improve the future prognosis of these patients.


REFERENCES

  1. Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019Jan15;92(3):e244–e252.

  2. Huang Q, Xie Y, Hu Z, Tang X. Anti-N-methyl-D-aspartate receptor encephalitis: A review of pathogenic mechanisms, treatment, prognosis. Brain Research. 2020;1727:146549. doi:10.1016/j.brainres.2019.146549

  3. Iglesias-Alonso, A., & Iglesias-García, C. (2017). Nota Clínica: Encefalitis anti-receptor N-metil-Daspartato con sintomatología psiquiátrica. Actas Españolas De Psiquiatría, 45(1), 39-40. Recuperado a partir de https://www.actaspsiquiatria.es/repositorio/19/105/ESP/19-105-ESP-39-46-493171.pdf

  4. Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2016;176(1):36-40. doi:10.1016/j.schres.2014.10.007

  5. Forrester A, Latorre S, O’Dea PK, Robinson C, Goldwaser EL, Trenton A, Tobia A, Aziz R, Dhawan S, Brennan A, Kurukumbi M, Dong Y, Benavides DR, Offurum AI, Anti-NMDAR Encephalitis: A Multidisciplinary Approach to Identification of the Disorder and Management of Psychiatric Symptoms, Psychosomatics (2020), doi: https://doi.org/10.1016/j.psym.2020.04.017.

  6. Gillinder, L., Warren, N., Hartel, G., Dionisio, S., & O'Gorman, C. (2019). EEG findings in NMDA encephalitis – A systematic review. Seizure: European Journal of Epilepsy, 65, 20-24. doi:https://doi.org/10.1016/j.seizure.2018.12.015

  7. Martínez, M. R., Bautista, G. P., Espínola-Nadurille, M., & Bayliss, L. (2019). Banderas rojas para sospechar encefalitis anti-NMDAr en un primer episodio psicótico: Reporte de dos casos. Revista Colombiana De Psiquiatría, 48(2), 127-130. doi:10.1016/j.rcp.2017.10.002

  8. Caycho-Gamarra GA, Quispe-Rivas MC, Carreazo-Pariasca NY, et al. Encefalitis anti-NMDAR: un caso pediátrico con afasia de expresión. Revista Mexicana de Pediatría. 2019;86(4):151-154. doi:10.35366/SP194E.

  9. Guasp, M., & Dalmau, J. (2018). Encefalitis por anticuerpos contra el receptor de NMDA. Medicina Clínica, 151(2), 71-79. doi:10.1016/j.medcli.2017.10.015

  10. Van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nature Reviews Neurology 2017; 13: 290-301. doi: 10.1038/nrneurol.2017.43

  11. Torricelli, R. E. (2019). ENCEFALITIS AUTOINMUNES. RECEPTOR ANTI-NMDA Y NUEVOS INMUNOFENOTIPOS. MEDICINA (Buenos Aires), 79(3), 54-59. doi: http://www.medicinabuenosaires.com/PMID/31603845.pdf

  12. Barquero-Madrigal, Alejandro. (2016). Encefalitis Autoinmune por Anticuerpos Antirreceptor de NMDA (Reporte de Caso). Neuroeje. 29. 26-30.

  13. Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiological Reviews. 2017; 97:839–87. doi: https://doi.org/10.1152/physrev.00010.2016

  14. Arias Reyes, F., Zegarra Lizana, P., Ortiz Alfaro, C., & Yshiyama Cervantes, R. (2016). Encefalitis por Anticuerpos Anti N-Metil-D-Aspartato (Nmda). Revista Experiencia En Medicina Del Hospital Regional Lambayeque, 2(3), 100 - 104. Recuperado a partir de http://rem.hrlamb.gob.pe/index.php/REM/article/view/58

  15. Gómez JF, Salazar O, Conde Z. Reporte de caso Índice de sospecha: manifestaciones psiquiátricas de la encefalitis por anticuerpos anti-NMDAR en pacientes pediátricos. Revista Colombiana de Psiquiatría. 2017;46(4):252–6. doi: https://doi.org/10.1016/j.rcp.2016.10.002

  16. Guasp, Mar & Módena, Yasmina & Armangue, Thaís & Dalmau, Josep & Graus, Francesc. (2020). Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis. Neurology - Neuroimmunology Neuroinflammation. 7. e659. 10.1212/NXI.0000000000000659

  17. Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet Neurology. 2019Nov1;18(11):1045–57. doi: https://doi.org/10.1016/S1474-4422(19)30244-3

  18. Zhang L, Wu MQ, Hao ZL, et al. Clinical characteristics, treatments, and outcomes of patients with anti-N-methyl-d-aspartate receptor encephalitis: A systematic review of reported cases. Epilepsy & Behavior. 2017;68:57-65. doi:10.1016/j.yebeh.2016.12.019




2020     |     www.medigraphic.com